On Tuesday, Immunic Inc (NASDAQ: IMUX) opened lower -4.84% from the last session, before settling in for the closing price of $0.6. Price fluctuations for IMUX have ranged from $0.55 to $1.39 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 26.01%. Company’s average yearly earnings per share was noted 38.11% at the time writing. With a float of $118.71 million, this company’s outstanding shares have now reached $120.28 million.
Considering the fact that the conglomerate employs 91 people, you should pay attention to its efficiency factor.
Immunic Inc (IMUX) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Immunic Inc is 1.31%, while institutional ownership is 52.23%. The most recent insider transaction that took place on Jun 13 ’25, was worth 16,694. In this transaction Executive Chairman of this company bought 20,000 shares at a rate of $0.83, taking the stock ownership to the 36,032 shares. Before that another transaction happened on Jun 05 ’25, when Company’s President and COO bought 12,512 for $0.79, making the entire transaction worth $9,884. This insider now owns 12,512 shares in total.
Immunic Inc (IMUX) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.25 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.24) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 38.11% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.73% during the next five years compared to 26.01% growth over the previous five years of trading.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
Check out the current performance indicators for Immunic Inc (IMUX). In the past quarter, the stock posted a quick ratio of 1.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.87, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.33 in one year’s time.
Technical Analysis of Immunic Inc (IMUX)
Compared to the last year’s volume of 1.3 million, its volume of 1.85 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 20.56%.
During the past 100 days, Immunic Inc’s (IMUX) raw stochastic average was set at 3.67%, which indicates a significant decrease from 14.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0432 in the past 14 days, which was lower than the 0.0574 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7167, while its 200-day Moving Average is $0.8746. Nevertheless, the first resistance level for the watch stands at $0.6040 in the near term. At $0.6339, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.6524. If the price goes on to break the first support level at $0.5556, it is likely to go to the next support level at $0.5371. Should the price break the second support level, the third support level stands at $0.5072.
Immunic Inc (NASDAQ: IMUX) Key Stats
There are currently 120,285K shares outstanding in the company with a market cap of 69.06 million. Presently, the company’s annual sales total 0 K according to its annual income of -100,510 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -25,580 K.
